Psychoactive Substance Use in Germany: Findings From the Epidemiological Survey of Substance Abuse (ESA) in 2024.

Background: Monitoring the use of psychoactive substances and the prevalence of substance-related disorders in the general population enables estimation of the extent of substance abuse and its effects on health and society. Methods: Data are from the Epidemiological Survey of Substance Abuse (ESA)...

Descripción completa

Detalles Bibliográficos
Publicado en:Deutsches Ärzteblatt International Vol. 122; no. 23; pp. 625 - 632
Autores principales: Olderbak, S., Hollweck, R., Krowartz, E. M., Möckl, J., Hoch, E.
Formato: Journal Article
Publicado: Deutscher Aerzte-Verlag GmbH 11/14/2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=190400067&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 190400067
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        18660452
        5F0N
      jtl: Deutsches Ärzteblatt International
      issn: 18660452
      maglogo: N
    pubinfo:
      dt: 11/14/2025
      vid: 122
      iid: 23
      pid: 25312
      pub: Deutscher Aerzte-Verlag GmbH
    artinfo:
      ui:
        190400067
        10.3238/arztebl.m2025.0157
        190400067
      ppf: 625
      ppct: 7
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
      tig:
        atl: Psychoactive Substance Use in Germany: Findings From the Epidemiological Survey of Substance Abuse (ESA) in 2024.
      aug:
        au:
          Olderbak, S.
          Hollweck, R.
          Krowartz, E. M.
          Möckl, J.
          Hoch, E.
        affil: IFT Center for Mental Health & Addiction Research, Munich, Germany
      sug:
      ab: Background: Monitoring the use of psychoactive substances and the prevalence of substance-related disorders in the general population enables estimation of the extent of substance abuse and its effects on health and society. Methods: Data are from the Epidemiological Survey of Substance Abuse (ESA) for 2024 (n = 7534, aged 18--64 years). Prevalence rates were calculated for the use of tobacco, alcohol, cannabis, illegal drugs, and medications, and for individuals who met the DSM-IV criteria for dependency or abuse. Rates were extrapolated to the German resident population aged 18 to 64 (51 480 168 people). Results: The most commonly used substance was alcohol, with a 30-day prevalence of 68.6% (35.3 million people), followed by non-opioid analgesics (31.5%) and conventional tobacco products (21.8%). The 12-month prevalence of cannabis use was 9.8% (5.1 million people). Dependence prevalences were 4.2% for alcohol, 8.3% for tobacco, 1.0% for cannabis, 0.1% for amphetamines, 0.1% for cocaine, 2.8% for analgesics, and 1.5% for hypnotics and sedatives. Abuse prevalences were 5.6% for analgesics, 0.5% for cannabis, 0.1% for cocaine, 0.1% for amphetamines, 1.1% for hypnotics and sedatives, and 3.3% for alcohol. Conclusion: The use of psychoactive substances in Germany is still widespread. Because of the effects of psychoactive substance use on health and society, continual monitoring is essential for the early detection of trends and the institution of targeted preventive and interventional measures.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N